(Q83159477)

English

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

scientific article published on 13 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alexandar Tzankov

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Kremer M

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Horn T

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Dechow T

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Quintanilla-Martínez L

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Fend F

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

13 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1315-1316

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16617316%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404231

0 references

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404231

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83159477&oldid=1466090654"